September 28, 2016 2:47 AM ET

Biotechnology

Company Overview of Coferon, Inc.

Company Overview

Coferon, Inc., a biotechnology company, develops a technology platform that enables the delivery of large molecular assemblies in component parts that are designed to self assemble on the target inside the cell. It also focuses on conducting research and development programs in the areas of epigenetic regulation and anti-infective aspects. The company was founded in 2009 and is based in Stony Brook, New York.

25 Health Sciences Drive

Mailbox 123

Stony Brook, NY 11790

United States

Founded in 2009

Phone:

800-983-8098

Fax:

800-983-8097

Key Executives for Coferon, Inc.

Chairman and Chief Executive Officer
Age: 56
Co-Founder and President
Academic Founder
Director of Business Development
Compensation as of Fiscal Year 2016.

Coferon, Inc. Key Developments

Coferon, Inc. Presents at The 23rd Annual Future Leaders in the Biotech Industry conference, Mar-11-2016 02:30 PM

Coferon, Inc. Presents at The 23rd Annual Future Leaders in the Biotech Industry conference, Mar-11-2016 02:30 PM. Venue: Millennium Broadway Hotel & Conference Center, 145 West 44th Street, Room 508, New York, New York, United States.

BlinkBio Inc. Announces Discovery Collaboration with Janssen Pharmaceuticals, Inc. to Optimize Self-Assembling Dimers Targeting Protein-Protein Interactions

BlinkBio Inc. announced that it has entered into a collaboration agreement with Janssen Pharmaceuticals Inc. in the discovery research area, in order to accelerate the optimization of prototype leads discovered in the company's self-assembling dimer program targeting the inhibition of Protein-Protein Interactions (PPIs). The BlinkBio proprietary self-assembling linker technology platform seeks to address challenging PPI targets like MYC and p53 by bridging the gap between small molecule drugs - which can enter target cells but generally lack a large enough binding footprint to provide sufficient potency and specificity - and large biomolecule drugs (like antibodies) which can generate outstanding target specificity but cannot access these key intracellular PPI targets. The technology utilizes a pair of monomers (comprised of a ligand, connectors and a bioorthogonal linker element) designed to access the cell and bind proximal binding sites on PPIs. The linker elements are designed to react to form a larger inhibitory dimer. The Janssen collaboration will build upon BlinkBio early proof-of-concept work that was published earlier this year (PLoS ONE (April 2015) 10(4):e0121793). Terms of the Agreement were not disclosed.

Coferon, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 01:30 PM

Coferon, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 01:30 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 9, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Coferon, Inc., please visit www.blinkbioinc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.